Womens cholesterol levels vary with phase of menstrual cycle

Aug 10th of 2010

Research Cardiovascular Sexual & Reproductive FEATURED BREAKING

National Institutes of Health researchers have shown that women's cholesterol levels correspond with monthly changes in estrogen levels. This natural variation, they suggest, might indicate a need to take into account the phases of a woman's monthly cycle before evaluating her cholesterol measures. On average, the total cholesterol level of the women in the study varied 19 percent over the course of the menstrual cycle.

FDA Approves First Generic Enoxaparin Sodium Injection to Prevent Deep Vain Thrombosis

Jul 23rd of 2010

Drugs Cardiovascular Blood & Lymphatic

The U.S. Food and Drug Administration today approved the first generic version of Lovenox (enoxaparin sodium injection), an anti-coagulant drug used to prevent deep vein thrombosis (DVT), a potentially deadly blood clotting condition.

Adverse Cardiovascular Events Reported in Testosterone Trial in Older Men

Jun 30th of 2010

Research Cardiovascular FEATURED

A clinical trial of testosterone treatment in older men, reported June 30 online in the New England Journal of Medicine, has found a higher rate of adverse cardiovascular events, such as heart attacks and elevated blood pressure, in a group of older men receiving testosterone gel compared to those receiving placebo. Due to these events, the treatment phase of the trial was stopped. The study was supported by a grant to Shalender Bhasin, M.D., at Boston Medical Center from the National Institu...

Novel Pathway (Cytochrome P450) May Open Doors for New Blood Pressure Treatments

Jun 22nd of 2010

Research Hypertension Cardiovascular FEATURED

Researchers have found that increasing certain proteins in the blood vessels of mice, relaxed the vessels, lowering the animal's blood pressure. The study provides new avenues for research that may lead to new treatments for hypertension.

Newer Heart Surgery for Infants Offers First-Year Survival Benefit over Traditional Procedure

Jun 2nd of 2010

Research Cardiovascular FEATURED

Infants born with a severely underdeveloped heart who undergo a newer surgical procedure are more likely to survive their first year and not require a heart transplant than those who have a more traditional surgical procedure, according to a report by researchers supported by the National Heart, Lung, and Blood Institute (NHLBI), which is part of the National Institutes of Health. The study of 549 newborns, however, suggests that after the first year, the two surgical procedures for the relat...

ADVERTISEMENT      |      ADVERTISE WITH US

Coronary Calcium Score to Traditional Risk Factors Improves Risk Assessment for Heart Disease

Apr 27th of 2010

Diseases Cardiovascular Heart Attack

Including a coronary artery calcium score in a risk assessment for future heart disease events, such as heart attacks, provides a better estimate in some populations than a standard coronary risk factors assessment, according to research supported by the National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health.

FDA Approves Asclera (polidocanol) to Treat Small Varicose Veins

Apr 4th of 2010

Diseases Cardiovascular Seniors & Aging

The U.S. Food and Drug Administration today approved Asclera (polidocanol) injection for the treatment of small types of abnormally swollen or twisted veins called varicose veins. Although they usually occur in the legs, varicose veins also can form in other parts of the body. Factors such as genetics, age, female gender, pregnancy, obesity, and prolonged periods of standing may increase the risk for varicose veins.

Scientists Map Genetic Regulatory Elements for the Heart

Feb 22nd of 2010

Research Genetics Cardiovascular

Scientists have devised a new computational model that can be used to reveal genetic regulatory elements responsible for development of the human heart and maintenance of its function. Although the teams focused on the heart, the computational method they developed is broadly applicable to other tissues, and was successfully used to identify regulatory elements for cells of the limbs and brain. Cataloging these regulatory sequences may improve understanding of diseases and lays the groundwor...

Heart Disease Awareness on the Rise But Prevention Still Critically Important for Women

Feb 8th of 2010

Diseases Cardiovascular FEATURED

In recognition of American Heart Month, the National Heart, Lung, and Blood Institute (NHLBI) and its heart disease awareness campaign - The Heart Truth - is reminding all American women that heart disease prevention remains critically important, despite that fact that awareness is at an all time high. More women than ever know that heart disease is their leading killer, yet millions of women are at risk, at increasingly younger ages.

FDA Approves Left Ventricular Assist System for Severe Heart Failure Patients

Jan 20th of 2010

Diseases Cardiovascular

The U.S. Food and Drug Administration today approved the HeartMate II, a continuous-flow, left ventricular assist system as a support for severe heart failure patients who are not acceptable candidates for heart transplantation.